Scalper1 News
Johnson & Johnson (JNJ) said Thursday that it received a binding offer of $4.15 billion from private-equity firm the Carlyle Group for its Ortho-Clinical Diagnostics business. J&J has until March 31 to decide whether to accept the offer. “This transaction is a result of our disciplined approach to portfolio management in order to achieve the greatest value for Johnson & Johnson,” J&J CEO Alex Gorsky said in a statement. The diversified medical Scalper1 News
Scalper1 News